Home » Topics » BioWorld

BioWorld
RSS

SYNTRO SHRINKS OFFERING AS WINDOW CLOSES

April 17, 1992

BIOTECH SELL-OFF: BAD, BUT NOT TERRIBLE

April 16, 1992

IMMUNOGEN STARTS EUROPEAN TRIALS

April 16, 1992

IMMURAID GETS ORPHAN DESIGNATION

April 16, 1992

SEPRACOR PATENT COVERS PROZAC ISOMER

April 16, 1992

FDA DEMANDS NEW TRIAL FOR CENTOXIN

April 16, 1992

BETA-AMYLOID PROTEIN LINKED TO BRAIN DAMAGE

April 16, 1992

ELAN BOOSTED AGAIN BY ANNOUNCEMENTS

April 16, 1992

NEW SUCCESS WITH MYOBLAST GENE THERAPY

April 16, 1992

GENE THERAPY FOR BRAIN DISEASE

April 16, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...